Infiltrating Duct and Lobular Carcinoma In Situ
Also known as: Infiltrating duct and lobular carcinoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00112 | Bevacizumab | 2 | Unknown Status | 1 |
| DB01101 | Capecitabine | 2 | Unknown Status | 1 |
| DB00531 | Cyclophosphamide | 2 | Unknown Status | 1 |
| DB01248 | Docetaxel | 2 | Unknown Status | 1 |
| DB00445 | Epirubicin | 2 | Unknown Status | 1 |
| DB00072 | Trastuzumab | 2 | Unknown Status | 1 |
| DB00361 | Vinorelbine | 2 | Unknown Status | 1 |